Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Macrophages have an important role in the maintenance of tissue homeostasis. To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition. Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth. However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, tumor cells produce lactate which induces the M2 phenotype of TAMs via stabilizing HIF‐1α and activating G‐protein‐coupled receptor 132 [210, 233, 234].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [233]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lactate is known to promote tumor growth [142], angiogenesis [143], and polarize macrophages to express a pro-tumor M2 phenotype [144].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [144]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies have demonstrated that lactate can improve the stability of the HIF-1α protein [9–11].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These findings indicate that lactate derived from the tumor microenvironment might facilitate HIF-1α-regulated angiogenesis in a hypoxia-independent manner [9].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Cited by
Items 101–200 of 1,014
Therapeutic targeting of the hypoxic tumour microenvironment
Singleton, D. C., Macann, A., & Wilson, W. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00539-4 · Cited by 484
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martín-Pérez, R., Serneels, J., Prenen, H., Ghesquière, B., Carmeliet, P., & Mazzone, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.008 · Cited by 496
“…stimuli, we built an in vitro system in which BM-derived macrophages (BMDMs) were stimulated with LLC tumor-conditioned medium (TCM) as previously shown (Colegio et al., 2014; Finisguerra et al., 2015) and thus generated TAM-like macrophages (TAMs-L) that were exposed to normoxia or hypoxia.”
MethodPeltanova, B., Raudenska, M., & Masarik, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0983-5 · Cited by 469
“Interestingly, tumor-derived lactate has been reported to contribute to the polarization of TAMs into the M2 phenotype [196].”
BackgroundChen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489
Systems Biology of Cancer Metastasis
Suhail, Y., Cain, M. P., Vanaja, K., Kurywchak, P. A., Levchenko, A., Kalluri, R., & Kshitiz (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.003 · Cited by 452
“Tumor associated macrophages (TAMs) can be stimulated by cancer cell-secreted lactate to promote angiogenesis(Colegio et al., 2014), a requirement for distant metastasis, and more recent findings suggest that TAMs induce early dissemination of Her2+ breast cancer cells(Linde et al., 2018).”
BackgroundIrizarry-Caro, R. A., McDaniel, M. M., Overcast, G. R., Jain, V. G., Troutman, T. D., & Pasare, C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009778117 · Cited by 457
Choo, Y. W., Kang, M., Kim, H. Y., Han, J., Kang, S., Lee, J.-R., Jeong, G.-J., Kwon, S. P., Song, S. Y., Go, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02446 · Cited by 465
Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism
Angajala, A., Lim, S., Phillips, J. B., Kim, J.-H., Yates, C., You, Z., & Tan, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01605 · Cited by 455
“In M2 macrophages, glycolysis is impaired due to low HIF-1α activity and low expression of the active 6-phosphofructo-2-kinase/ fructose-2,6-biphosphatase 1.”
BackgroundInfluentialLactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity
Wang, J. X., Choi, S. Y. C., Niu, X., Kang, N., Xue, H., Killam, J., & Wang, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218363 · Cited by 460
“In particular, lactic acid secreted by cancer cells has a critical signaling function in the TME to induce M2 polarization [11].”
BackgroundEnergy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
The Intersection of Epigenetics and Metabolism in Trained Immunity
Fanucchi, S., Domínguez-Andrés, J., Joosten, L. A. B., Netea, M. G., & Mhlanga, M. M. (2021) · Immunity · doi:10.1016/j.immuni.2020.10.011 · Cited by 428
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Adipose tissue macrophages: going off track during obesity
Boutens, L., & Stienstra, R. (2016) · Diabetologia · doi:10.1007/s00125-016-3904-9 · Cited by 428
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
“On one hand, metabolites of tumor cells promote immunosuppressive effects, 295,296 and in turn, phagocytosis of TAMs facilitates nutrient accumulation to meet energy requirement of tumor cells.”
BackgroundAARS1 and AARS2 sense l-lactate to regulate cGAS as global lysine lactyltransferases
Li, H., Liu, C., Li, R., Zhou, L., Ran, Y., Yang, Q., Huang, H., Lu, H., Song, H., Yang, B., et al. (2024) · Nature · doi:10.1038/s41586-024-07992-y · Cited by 406
“The corrected and normalized data were fit to the single exponential model using GraphPad Prism 8.”
InfluentialMyeloid Cell-Derived Arginase in Cancer Immune Response
Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzynska, Z., Jasinski, M., Nowis, D., & Golab, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00938 · Cited by 424
“TAMs in lung cancer and melanoma also express more ARG1 than all other cells within tumor combined (178) and have over 20 times higher expression of ARG1 as compared with peritoneal macrophages (184).”
BackgroundThe ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 430
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436
The Apoptosis Paradox in Cancer
Morana, O., Wood, W., & Gregory, C. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031328 · Cited by 420
“Much remains to be learned about how apoptosis drives the M2-like phenotype of TAMs in the ORN, though it is notable that TAM production of lactate appears to be an important pathway in metabolic programming of pro-tumour, M2-like macrophage activation [86].”
BackgroundMetabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Control of macrophage metabolism and activation by mTOR and Akt signaling
Covarrubias, A. J., Aksoylar, H. I., & Horng, T. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.08.001 · Cited by 424
“Lactate stabilizes HIF1α expression in the TAMs, allowing for induction of Arginase and pro-tumoral activities, perhaps via Arginase-dependent production of polyamines that are essential for cellular proliferation(32).”
BackgroundShalova, I. N., Lim, J. Y., Chittezhath, M., Zinkernagel, A. S., Beasley, F., Hernández-Jiménez, E., Toledano, V., Cubillos-Zapata, C., Rapisarda, A., Chen, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.001 · Cited by 419
“An immunosuppressive role for HIF1a is also supported by studies in tumors, where HIF1a was instrumental in polarizing tumor associated macrophages to an M2-like phenotype and driving myeloid-derived suppressor cells to their immunosuppressive phenotype (Colegio et al., 2014; Corzo et al., 2010).”
Yin, M., Li, X., Tan, S., Zhou, H. J., Ji, W., Bellone, S., Xu, X., Zhang, H., Santin, A. D., Lou, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87252 · Cited by 417
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 413
“In addition to direct nutrition competition, tumorderived lactate is key to remodeling immunity within the microenvironment, inducing the M2-like phenotype of TAMs and reducing CD8+ cytotoxic T cell functions [194, 195].”
BackgroundStacpoole, P. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx071 · Cited by 402
Palmieri, E. M., Menga, A., Martín-Pérez, R., Quinto, A., Riera-Domingo, C., De Tullio, G., Hooper, D. C., Lamers, W. H., Ghesquière, B., McVicar, D. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.054 · Cited by 404
“Altogether, these data demonstrate that the inhibition of GS in TAMs hinders their angiogenic, immunosuppressive, and pro-metastatic potential.”
InfluentialMonocarboxylate transporters in the brain and in cancer
Pérez-Escuredo, J., Van Hée, V. F., Sboarina, M., Falces, J., Payen, V. L., Pellerin, L., & Sonveaux, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.013 · Cited by 402
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
Yin, H., Zhang, X., Yang, P., Zhang, X., Peng, Y., Li, D., Yu, Y., Wu, Y., Wang, Y., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21514-8 · Cited by 404
Mitochondrial control of immunity: beyond ATP
Mehta, M. M., Weinberg, S. E., & Chandel, N. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.66 · Cited by 396
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 389
“…immunity by TAMs involves the following mechanisms: (1) tumor cells produce IL-10, which induces the expression of PD-L1 on the surface of TAMs, 88 binds to PD-1 on the surface of T cells in the TME, and inhibits cytotoxic T-cell function; (2) TAMs produce CCL22, which recruits regulatory T…”
Diverse Functions of Macrophages in Different Tumor Microenvironments
Yang, M., McKay, D., Pollard, J. W., & Lewis, C. E. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1367 · Cited by 387
“Indeed, lactic acid can stimulate expression of VEGFA by macrophages (87).”
Antigen-Presenting Cells in the Skin
Kashem, S. W., Haniffa, M., & Kaplan, D. H. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052215 · Cited by 361
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
Chen, D., Zhang, X., Li, Z., & Zhu, B. (2021) · Theranostics · doi:10.7150/thno.51777 · Cited by 390
“The tumor-derived succinate is taken up through succinate receptor (SUCNR1) and results in the polarization of TAMs into a pro-tumoral form via the SUCNR1/PI3K/ HIF1α signaling pathway to enhance tumor metastasis, which can also be mediated by autocrine succinate [34].”
BackgroundInfluentialMacrophage Polarization and Osteoporosis: A Review
Muñoz, J., Akhavan, N. S., Mullins, A. P., & Arjmandi, B. H. (2020) · Nutrients · doi:10.3390/nu12102999 · Cited by 384
“produce high succinate levels which increase IL-1β and promote inflammation via the stabilization of hypoxia inducible factor 1 alpha (HIF1α) [39]; (2) Oxygen concentrations—hypoxic conditions favor M2 macrophage polarization and resolution of inflammation [40]; (3) Acidification—increased lactic acid production in tu…”
BackgroundMetabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 374
“Lactic acid also induces M2-polarization in TAMs via HIF-1α stabilization (96).”
BackgroundHarmon, C., Robinson, M. W., Hand, F., Almuaili, D., Mentor, K., Houlihan, D. D., Hoti, E., Lynch, L., Geoghegan, J., & O'Farrelly, C. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0481 · Cited by 360
Macrophages in Renal Injury and Repair
Huen, S. C., & Cantley, L. G. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034219 · Cited by 377
Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release
Morioka, S., Perry, J. S. A., Raymond, M. H., Medina, C. B., Zhu, Y., Zhao, L., Serbulea, V., Onengut-Gumuscu, S., Leitinger, N., Kucenas, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0735-5 · Cited by 363
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
Zhang, M., Di Martino, J. S., Bowman, R. L., Campbell, N. R., Baksh, S. C., Simon-Vermot, T., Kim, I. S., Haldeman, P., Mondal, C., Yong-Gonzales, V., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1371 · Cited by 360
“A recent single-cell sequencing study demonstrated significant heterogeneity within the immune component of the TME (5), which may in part be related to the ability of immune cells such as macrophages to respond to lactate secreted from tumor cells (6).”
BackgroundSimilarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373
“Tumorderived lactic acid was taken up by macrophages and promoted their polarization to the suppressiveM2 lineage via HIF-1a-mediated expression of M2-characteristic arginase 1 (Colegio et al., 2014).”
BackgroundMetabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Chen, L., Huang, L., Gu, Y., Cang, W., Sun, P., & Xiang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911943 · Cited by 344
“Moreover, tumor-derived lactate can induce tumor-associated macrophage (TAM) polarization to the M2 immunosuppressive phenotype by binding to the lactate-sensitive receptor-G proteincoupled receptor 132(GPR132) [57,58].”
BackgroundTumor-Associated Macrophages: Implications in Cancer Immunotherapy
Petty, A. J., & Yang, Y. (2017) · Immunotherapy · doi:10.2217/imt-2016-0135 · Cited by 363
Ju, J., Zhang, H., Lin, M., Yan, Z., An, L., Cao, Z., Geng, D., Yue, J., Tang, Y., Tian, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174587 · Cited by 338
“In this regard, we performed lactylation proteomics in HGC27 cells, which revealed that several impor- tin-α subunits (KPNA1, 3, 4, and 6) were lactylated (Supple-Figure (Supplemental Figure 2G) and that YAP lactylation was completely abolished by K90R mutation (Supplemental Figure 2H) and YAP…”
Wang, H., Tian, T., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168470 · Cited by 364
“This process results in macrophage recruitment and phenotypic polarization towards the M2 macrophage state, mediated by hypoxia inducible factor-1α (HIF1α) [102].”
BackgroundLactic acid and lactate: revisiting the physiological roles in the tumor microenvironment
Apostolova, P., & Pearce, E. L. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.10.005 · Cited by 346
Gao, F., Tang, Y., Liu, W., Zou, M., Huang, C., Liu, C., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201904639 · Cited by 357
Metabolic communication in the tumour–immune microenvironment
Kao, K.-C., Vilbois, S., Tsai, C.-H., & Ho, P.-C. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-01002-x · Cited by 349
Tumor-associated macrophages: an effective player of the tumor microenvironment
Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295257 · Cited by 333
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Tian, L.-Y., Smit, D. J., & Jücker, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032652 · Cited by 329
Metabolism as a guiding force for immunity
Jung, J., Zeng, H., & Horng, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0217-x · Cited by 346
Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24
Yu, T., Gan, S., Zhu, Q., Dai, D., Li, N., Wang, H., Chen, X., Hou, D., Wang, Y., Pan, Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12384-2 · Cited by 348
Tissue‐resident macrophages: then and now
Davies, L. C., & Taylor, P. R. (2015) · Immunology · doi:10.1111/imm.12451 · Cited by 334
De Leo, A., Ugolini, A., Yu, X., Scirocchi, F., Scocozza, D., Peixoto, B., Pace, A., D’Angelo, L., Liu, J. K. C., Etame, A. B., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.006 · Cited by 319
The enhancement of glycolysis regulates pancreatic cancer metastasis
Yang, J., Ren, B., Yang, G., Wang, H., Chen, G., You, L., Zhang, T., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03278-z · Cited by 347
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Rachidi, S., Metelli, A., Riesenberg, B., Wu, B. X., Nelson, M. H., Wallace, C., Paulos, C. M., Rubinstein, M. P., Garrett-Mayer, E., Hennig, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7911 · Cited by 335
Endothelial Cell Metabolism in Health and Disease
Rohlenova, K., Veys, K., Miranda-Santos, I., De Bock, K., & Carmeliet, P. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.010 · Cited by 335
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Xia, A., Zhang, Y., Xu, J., Yin, T., & Lu, X.-J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 341
Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning
de Couto, G., Gallet, R., Cambier, L., Jaghatspanyan, E., Makkar, N., Dawkins, J. F., Berman, B. P., & Marbán, E. (2017) · Circulation · doi:10.1161/circulationaha.116.024590 · Cited by 340
Zhang, M., Hutter, G., Kahn, S. A., Azad, T. D., Gholamin, S., Xu, C. Y., Liu, J., Achrol, A. S., Richard, C., Sommerkamp, P., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153550 · Cited by 330
Wilde, L., Roche, M., Domingo-Vidal, M., Tanson, K., Philp, N., Curry, J., & Martinez-Outschoorn, U. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.004 · Cited by 326
“Similar findings with metabolic coupling between stromal and cancer cells involving lactate, pyruvate, beta-hydroxybutyrate, acetate, fatty acids, glutamine and alanine have been discovered in many human malignancies including breast, ovarian, prostate, liver, colon, pancreatic and head and neck squamous cell cancer (…”
ResultExercise benefits on Alzheimer’s disease: State-of-the-science
Valenzuela, P. L., Castillo-García, A., Morales, J. S., de la Villa, P., Hampel, H., Emanuele, E., Lista, S., & Lucia, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101108 · Cited by 337
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
Arlauckas, S. P., Garren, S. B., Garris, C. S., Kohler, R. H., Oh, J., Pittet, M. J., & Weissleder, R. (2018) · Theranostics · doi:10.7150/thno.26888 · Cited by 331
“This is consistent with prior work having demonstrated that different tumor microenvironment cues can influence Arg1 expression [19,25].”
BackgroundResultTumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133308 · Cited by 305
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
“In fact, the metabolism of TAMs has been recently shown to control tumor blood vessel morphogenesis and metastasis (24).”
BackgroundResultInfluentialMolecular and epigenetic basis of macrophage polarized activation
Porta, C., Riboldi, E., Ippolito, A., & Sica, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.003 · Cited by 320
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 326
Rewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P., Carracedo, A., & Erez, A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0054-z · Cited by 323
Lactic Acid: No Longer an Inert and End-Product of Glycolysis
Sun, S., Li, H., Chen, J., & Qian, Q. (2017) · Physiology · doi:10.1152/physiol.00016.2017 · Cited by 314
“1 , independent of hypoxia (25, 28, 93, 94, 131) (FIGURE 2).”
Park, J.-S., Kim, I.-K., Han, S., Park, I., Kim, C., Bae, J., Oh, S. J., Lee, S., Kim, J. H., Woo, D.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.018 · Cited by 327
“Together, although the effect of ABTAA on immune cell infiltration is varied in our three tumor models, presumably due to differences in nature, microenvironment, immune/inflammatory responses, and other attributes of cancers, it is relatively favorable in suppressing tumor progression and metastasis and may yield a b…”
BackgroundMacrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
Geeraerts, X., Bolli, E., Fendt, S.-M., & Van Ginderachter, J. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00289 · Cited by 312
“While Vegf induces angiogenesis, ARG-1 contributes to tumor growth by the generation of polyamines which act as a proliferative signal for mammalian cancer cells (81).”
BackgroundLactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
“For instance, in M1 macrophages treated with exogenous lactate, lysine lactylation enrichment at the Arg1 promoter and increased gene expression were observed.”
BackgroundInfluentialTumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Yang, K., Xu, J., Fan, M., Tu, F., Wang, X., Ha, T., Williams, D. L., & Li, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587913 · Cited by 301
“reported that cancer cell-derived lactate induces the M2-like polarization of cancer-associated macrophages, which contributes to an immunosuppressive microenvironment for cancer development (5).”
BackgroundInfluentialMetabolic orchestration of the wound healing response
Eming, S. A., Murray, P. J., & Pearce, E. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.017 · Cited by 315
Crosstalk between glucose metabolism, lactate production and immune response modulation
Ye, L., Jiang, Y., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.11.001 · Cited by 306
Monocytes in the Tumor Microenvironment
Ugel, S., Canè, S., De Sanctis, F., & Bronte, V. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013058 · Cited by 314
Muraille, E., Leo, O., & Moser, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00603 · Cited by 311
“This latter study is in accordance with two recent reports showing (i) that tumor-infiltrating macrophages in hypoxic areas displayed an altered pro-tumoral phenotype, characterized by impaired M1-type function (61) and (ii) that tumor-derived lactic acid induced vegf and Arg1 and the M2-like polarization of tumor-ass…”
ResultKim, H. Y., Kim, T. J., Kang, L., Kim, Y.-J., Kang, M. K., Kim, J., Ryu, J. H., Hyeon, T., Yoon, B.-W., Ko, S.-B., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119942 · Cited by 321
Brown, T. P., Bhattacharjee, P., Ramachandran, S., Sivaprakasam, S., Ristic, B., Sikder, M. O. F., & Ganapathy, V. (2020) · Oncogene · doi:10.1038/s41388-020-1216-5 · Cited by 304
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
Bao, M. H.-R., & Wong, C. C.-L. (2021) · Cells · doi:10.3390/cells10071715 · Cited by 316
“Additionally, in mice tumor associated macrophage, lactate promoted a shift from anti-tumoral M1 phenotype to protumoral M2 phenotype in a HIF-1-dependent manner [81] (Figure 4).”
BackgroundT cell metabolic fitness in antitumor immunity
Siska, P. J., & Rathmell, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.007 · Cited by 312
Lactate: A key regulator of the immune response
Llibre, A., Kucuk, S., Gope, A., Certo, M., & Mauro, C. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.008 · Cited by 283
Wang, B., Zhao, Q., Zhang, Y., Liu, Z., Zheng, Z., Liu, S., Meng, L., Xin, Y., & Jiang, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01820-7 · Cited by 315
“M2-like polarization of TAMs, which is partly mediated by HIF-1α activation [58].”
BackgroundRestricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Renner, K., Bruss, C., Schnell, A., Koehl, G., Becker, H. M., Fante, M., Menevse, A.-N., Kauer, N., Blazquez, R., Hacker, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.068 · Cited by 306
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Anfray, C., Ummarino, A., Andón, F. T., & Allavena, P. (2019) · Cells · doi:10.3390/cells9010046 · Cited by 304
“Acidification of the TME caused by lactate derived from enhanced glycolytic activity of cancer cells induces regulatory macrophages through G protein‐couple receptor (GPCR) and IL‐1 beta‐ converting enzyme (ICE) [21], enhances VEGF and arginase expression, thus promoting M2‐like features of TAMs [22].”
BackgroundInflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Wang, L., Liu, Y., Dai, Y., Tang, X., Yin, T., Wang, C., Wang, T., Dong, L., Shi, M., Qin, J., et al. (2023) · Gut · doi:10.1136/gutjnl-2021-326070 · Cited by 306
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M. E., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 305
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
The hypoxia–lactate axis tempers inflammation
Ivashkiv, L. B. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0259-8 · Cited by 305
Metabolic Modulation in Macrophage Effector Function
Diskin, C., & Pålsson-McDermott, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00270 · Cited by 291
“Lactate secreted from tumor cells was found to drive M2 polarization in TAMs, which facilitated tumor growth (47).”
BackgroundCAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Kankeu Fonkoua, L. A., Sirpilla, O., Sakemura, R., Siegler, E. L., & Kenderian, S. S. (2022) · Molecular Therapy - Oncolytics · doi:10.1016/j.omto.2022.03.009 · Cited by 282
“Elevated lactate levels produced by hypermetabolic tumor cells have been associated with nuclear factor of activated T cells (NFAT)-mediated dampening of T cell signaling,(40) Treg cell expansion,(41) and polarization of macrophages towards an immunosuppressive M2 phenotype.(42) The interactions between tumor cells, t…”
BackgroundExercise-dependent regulation of the tumour microenvironment
Koelwyn, G. J., Quail, D. F., Zhang, X., White, R. M., & Jones, L. W. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.78 · Cited by 296
Macrophages as Key Drivers of Cancer Progression and Metastasis
Nielsen, S. R., & Schmid, M. C. (2017) · Mediators of Inflammation · doi:10.1155/2017/9624760 · Cited by 298
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
“polarisation of tumour-associated macrophages [83] (Fig.”
The tumor microenvironment in esophageal cancer
Lin, E. W., Karakasheva, T. A., Hicks, P. D., Bass, A. J., & Rustgi, A. K. (2016) · Oncogene · doi:10.1038/onc.2016.34 · Cited by 303
Liu, M., O’Connor, R. S., Trefely, S., Graham, K., Snyder, N. W., & Beatty, G. L. (2019) · Nature Immunology · doi:10.1038/s41590-018-0292-y · Cited by 294
Up-down regulation of HIF-1α in cancer progression
Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 283
Metadata
- Authors
- Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R.
- Affiliations
- Yale Cancer Center (US)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- ORCID
- Venue
- Nature
- Published
- 2014-07-13
- Volume
- 513
- Issue
- 7519
- Pages
- 559-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4301845
- OpenAlex
- W2063632665
- Cited by
- 3,046
- References
- 24
- Citations by year
- 2026: 359 · 2025: 338 · 2024: 311 · 2023: 338 · 2022: 345 · 2021: 314 · 2020: 269 · 2019: 213 · 2018: 159 · 2017: 161 · 2016: 113 · 2015: 87 · 2014: 23
- FWCI
- 58.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000142)
- National Cancer Institute (R01CA157461, K08CA172580, P50CA121974, CA157461)
- National Institute of Allergy and Infectious Diseases (AI089771, R01AI089771, R37AI046688, AI046688, R01AI046688)
- National Center for Research Resources (KL2RR024138)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumour-associated macrophages, lactic acid, M2 macrophage polarization, hypoxia-inducible factor-1α, vascular endothelial growth factor, arginase-1, tumor growth, tumor microenvironment, glycolysis, tissue homeostasis
- MeSH terms
- Animals, Arginase, Cell Communication, Cell Division, Female, Glycolysis, Homeostasis, Macrophages, Male, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, RNA, Messenger, Solubility, Up-Regulation, Culture Media, Conditioned, Carcinoma, Lewis Lung, Lactic Acid, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.